Literature DB >> 9813277

Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy.

S Maillet1, J Vion-Dury, S Confort-Gouny, F Nicoli, N W Lutz, P Viout, P J Cozzone.   

Abstract

High resolution magnetic resonance spectroscopy (MRS) of cerebrospinal fluid (CSF) is a non-destructive analytical method which allows rapid and simultaneous detection of molecules involved in intermediary and oxidative metabolic pathways. We developed a protocol suitable for routine MRS analysis of lyophilized CSF samples. This procedure guarantees sample integrity, from CSF collection to spectrum acquisition. MRS analysis of blood serum was included in our protocol as a complementary method to CSF analysis. This protocol can contribute to establish MRS of CSF as a new analytical tool to better understand the metabolic processes involved in neurological diseases. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813277     DOI: 10.1016/s1385-299x(98)00033-6

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  14 in total

1.  MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata.

Authors:  Angèle Viola; Sylviane Confort-Gouny; Jean-Philippe Ranjeva; Brigitte Chabrol; Charles Raybaud; Francisca Vintila; Patrick J Cozzone
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  Is NMR metabolic profiling of spent embryo culture media useful to assist in vitro human embryo selection?

Authors:  Lydie Nadal-Desbarats; Ségolène Veau; Hélène Blasco; Patrick Emond; Dominique Royere; Christian R Andres; Fabrice Guérif
Journal:  MAGMA       Date:  2012-08-10       Impact factor: 2.310

3.  Impact of prenatal stress on 1H NMR-based metabolic profiling of rat amniotic fluid.

Authors:  Sophie Serriere; Laurent Barantin; François Seguin; François Tranquart; Lydie Nadal-Desbarats
Journal:  MAGMA       Date:  2011-05-26       Impact factor: 2.310

Review 4.  Methodological Developments for Metabolic NMR Spectroscopy from Cultured Cells to Tissue Extracts: Achievements, Progress and Pitfalls.

Authors:  Norbert W Lutz; Monique Bernard
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

5.  1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis.

Authors:  Hélène Blasco; Philippe Corcia; Caroline Moreau; Ségolène Veau; Clémentine Fournier; Patrick Vourc'h; Patrick Emond; Paul Gordon; Pierre-François Pradat; Julien Praline; David Devos; Lydie Nadal-Desbarats; Christian R Andres
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

6.  High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.

Authors:  A Viola; F Nicoli; B Denis; S Confort-Gouny; Y Le Fur; J-P Ranjeva; P Viout; P J Cozzone
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

Review 7.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs.

Authors:  K W Jordan; C B Adkins; L Su; E F Halpern; E J Mark; D C Christiani; L L Cheng
Journal:  Lung Cancer       Date:  2009-06-25       Impact factor: 5.705

9.  NMR-based metabolomics of human cerebrospinal fluid identifies signature of brain death.

Authors:  Martha E García-Aguilera; Eduardo Rodríguez de San Miguel; Jocelyn Cruz-Pérez; Lucinda Aguirre-Cruz; Christian M Ramirez-Alfaro; Nuria Esturau-Escofet
Journal:  Metabolomics       Date:  2021-04-16       Impact factor: 4.290

10.  Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response.

Authors:  Uwe Himmelreich; Richard Malik; Till Kühn; Heide-Marie Daniel; Ray L Somorjai; Brion Dolenko; Tania C Sorrell
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.